SMT201500160B - Nuovi derivati isochinolinici 6,7-disostituiti e loro uso - Google Patents
Nuovi derivati isochinolinici 6,7-disostituiti e loro usoInfo
- Publication number
- SMT201500160B SMT201500160B SM201500160T SM201500160T SMT201500160B SM T201500160 B SMT201500160 B SM T201500160B SM 201500160 T SM201500160 T SM 201500160T SM 201500160 T SM201500160 T SM 201500160T SM T201500160 B SMT201500160 B SM T201500160B
- Authority
- SM
- San Marino
- Prior art keywords
- disubstituted
- isoquinoline derivatives
- new isoquinoline
- new
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10397511A EP2420237A1 (en) | 2010-08-11 | 2010-08-11 | Fluorinated derivatives of endogenous isoquinolines for use in the treatment of diseases mediated through endogenous isoquinoline pathways |
PCT/FI2011/050707 WO2012020170A1 (en) | 2010-08-11 | 2011-08-10 | Novel 6,7-disubstituted-isoquinoline derivatives and their use |
EP11770473.4A EP2603217B1 (en) | 2010-08-11 | 2011-08-10 | Novel 6,7-disubstituted-isoquinoline derivatives and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
SMT201500160B true SMT201500160B (it) | 2015-09-07 |
Family
ID=43827823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SM201500160T SMT201500160B (it) | 2010-08-11 | 2015-07-03 | Nuovi derivati isochinolinici 6,7-disostituiti e loro uso |
Country Status (16)
Country | Link |
---|---|
US (1) | US8815898B2 (hr) |
EP (2) | EP2420237A1 (hr) |
CN (1) | CN103179971A (hr) |
CA (1) | CA2808016C (hr) |
CY (1) | CY1116588T1 (hr) |
DK (1) | DK2603217T3 (hr) |
ES (1) | ES2541401T3 (hr) |
HR (1) | HRP20150668T1 (hr) |
HU (1) | HUE026482T2 (hr) |
PL (1) | PL2603217T3 (hr) |
PT (1) | PT2603217E (hr) |
RS (1) | RS54081B1 (hr) |
RU (1) | RU2636938C2 (hr) |
SI (1) | SI2603217T1 (hr) |
SM (1) | SMT201500160B (hr) |
WO (1) | WO2012020170A1 (hr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105461626B (zh) * | 2015-12-17 | 2018-05-08 | 浙江工业大学 | 芳环或稠杂环联3,4-二氢异喹啉类共轭结构化合物及其应用 |
CN105585527B (zh) * | 2015-12-17 | 2018-06-26 | 浙江工业大学 | 2-(3,4-二氢异喹啉-1(2h)-亚基)乙腈类化合物及其应用 |
FI130627B (en) | 2021-03-31 | 2023-12-18 | Equinorm Ltd | NEW HETEROCYCLIC COMPOUNDS AND THEIR USE |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2716548B2 (ja) * | 1989-11-01 | 1998-02-18 | 雅昭 廣部 | パーキンソニズム予防・治療剤 |
DE9017900U1 (de) | 1990-12-22 | 1993-01-28 | Boehringer Ingelheim Kg, 55218 Ingelheim | 3,4-Dihydro-1-benzyl-6,7-dimethoxy-α- [di-2-(2,3,4-trimethoxyphenyl)ethyl] aminocarbonyl-isochinolin |
US5491148A (en) | 1991-04-26 | 1996-02-13 | Syntex (U.S.A.) Inc. | Isoquinolinone and dihydroisoquinolinone 5-HT3 receptor antagonists |
US5246943A (en) * | 1992-05-19 | 1993-09-21 | Warner-Lambert Company | Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties |
ES2230618T3 (es) | 1996-09-27 | 2005-05-01 | Aventis Pharmaceuticals Inc. | Reaccion de pictet-spengler para la sintesis de tetrahidroisoquinolinas y compuestos heterociclicos relacionados. |
KR100878855B1 (ko) * | 1999-11-03 | 2009-01-15 | 에이엠알 테크놀로지, 인크. | 4-페닐-치환 테트라히드로이소퀴놀린, 및 노르에피네프린과 도파민과 세로토닌의 재흡수를 차단하기 위한 이의 용도 |
WO2006035280A1 (en) | 2004-09-27 | 2006-04-06 | Ranbaxy Laboratories Limited | 3,4-dihydroisoquinoline compounds as muscrinic receptor antagonists for the treatment of respiratory, urinary and gastrointestinal diseases |
US20060111393A1 (en) * | 2004-11-22 | 2006-05-25 | Molino Bruce F | 4-Phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
EP2090576A1 (en) * | 2008-02-01 | 2009-08-19 | Merz Pharma GmbH & Co.KGaA | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators |
-
2010
- 2010-08-11 EP EP10397511A patent/EP2420237A1/en not_active Withdrawn
-
2011
- 2011-08-10 CA CA2808016A patent/CA2808016C/en not_active Expired - Fee Related
- 2011-08-10 ES ES11770473.4T patent/ES2541401T3/es active Active
- 2011-08-10 RS RS20150436A patent/RS54081B1/en unknown
- 2011-08-10 EP EP11770473.4A patent/EP2603217B1/en active Active
- 2011-08-10 PT PT117704734T patent/PT2603217E/pt unknown
- 2011-08-10 SI SI201130527T patent/SI2603217T1/sl unknown
- 2011-08-10 PL PL11770473T patent/PL2603217T3/pl unknown
- 2011-08-10 RU RU2013110377A patent/RU2636938C2/ru not_active Application Discontinuation
- 2011-08-10 US US13/814,987 patent/US8815898B2/en active Active
- 2011-08-10 WO PCT/FI2011/050707 patent/WO2012020170A1/en active Application Filing
- 2011-08-10 HU HUE11770473A patent/HUE026482T2/en unknown
- 2011-08-10 DK DK11770473.4T patent/DK2603217T3/en active
- 2011-08-10 CN CN2011800490170A patent/CN103179971A/zh active Pending
-
2015
- 2015-06-19 HR HRP20150668TT patent/HRP20150668T1/hr unknown
- 2015-07-02 CY CY20151100573T patent/CY1116588T1/el unknown
- 2015-07-03 SM SM201500160T patent/SMT201500160B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
RU2013110377A (ru) | 2014-09-20 |
PL2603217T3 (pl) | 2015-09-30 |
RU2636938C2 (ru) | 2017-11-29 |
EP2603217A1 (en) | 2013-06-19 |
EP2420237A1 (en) | 2012-02-22 |
HRP20150668T1 (hr) | 2015-09-11 |
CN103179971A (zh) | 2013-06-26 |
HUE026482T2 (en) | 2016-06-28 |
SI2603217T1 (sl) | 2015-08-31 |
PT2603217E (pt) | 2015-08-26 |
CA2808016A1 (en) | 2012-02-16 |
ES2541401T3 (es) | 2015-07-20 |
CA2808016C (en) | 2018-10-30 |
US8815898B2 (en) | 2014-08-26 |
CY1116588T1 (el) | 2017-03-15 |
RS54081B1 (en) | 2015-10-30 |
US20130137719A1 (en) | 2013-05-30 |
DK2603217T3 (en) | 2015-07-13 |
EP2603217B1 (en) | 2015-04-08 |
WO2012020170A1 (en) | 2012-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201600226B (it) | Alcune amminopirimidine, loro composizioni e metodi per il loro uso | |
SMT201600157B (it) | Composti di carbammoilpiridone policiclici e loro uso farmaceutico | |
SMT201600354B (it) | Composti di beta-lattame sostituiti da ammidina, loro preparazione ed uso come agenti antibatterici | |
SMT201500213B (it) | Alcune triazolopirazine, loro composizioni e metodi d'uso | |
SMT201600198B (it) | Derivati di 1,2,4-triazina-4-ammina | |
BR112013023681A2 (pt) | compostos de álcool propargílico 6,5-heterocíclico e uso dos mesmos | |
IT1403847B1 (it) | Composizioni farmaceutiche comprendenti rifaximina e loro uso. | |
BR112013015592A2 (pt) | dericados de biciclo-[3.2.1]-octilamida e usos dos mesmos | |
BR112012002349A2 (pt) | composto,e, uso do mesmo | |
BR112014014763A2 (pt) | novos conjugados de anticorpo-medicamento (adcs) e uso dos mesmos | |
CO6930362A2 (es) | Compuesto heterocíclico y su uso | |
SMT201600223B (it) | Composti eterociclici e loro uso come modulatori di tirosin chinasi di tipo iii | |
BR112012031226A2 (pt) | composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica | |
BR112013010988A2 (pt) | composição fluída e uso | |
BRPI1010024A2 (pt) | derivados de aminopirrolidinona e uso dos mesmos | |
BR112013006016A2 (pt) | compostos de azabenzotiazol, composições e métodos de uso | |
BRPI0823082A2 (pt) | Uso derivados de sesquiterpeno | |
CO6781486A2 (es) | Compuestos y su uso | |
SMT201400185B (it) | Derivati di 3,4,4A, 10B-tetraidro-1H-tiopirano-[4,3-C]isochinolina | |
BRPI1011036A2 (pt) | uso | |
CR20140362A (es) | Fenilimidazopirazoles sustituidos y su uso | |
SMT201400157B (it) | Derivati di 2-piridin-2-il-pirazol-3(2H)-one, loropreparazione e loro uso terapeutico | |
BR112014025416A2 (pt) | AGENTES ANTIMALÁRICOS, COMPOSIÇÃO FARMACEUTICA COMPREENDENDO-OS E USO Dos MESMOS. | |
IL238452A0 (en) | History of new modified 4,1-dithienes and their use as fungicides | |
BR112013023575A2 (pt) | derivado de octaidrotienoquinolina, composição farmacêutica compreendendo o derivado, e uso destes |